ArticleAnaesthesiology intensive therapy2020
SpO2, heart rate, and arterial blood pressure during successful or failed application of non-invasive ventilation after delivery - a single-centre study.
Article in Anaesthesiology intensive therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSpO2, heart rate, and systolic, diastolic, and mean arterial blood pressure are among the commonly applied and most frequently chosen indicators of well-being of newborns in intensive care units. Objective: to determine the relationship between the aforementioned parameters and the status of newborns depending on the outcome of the Infant Flow (I-F) therapy, and the development of complications in the form of pneumothorax. MATERIAL AND
methodsA retrospective single-centre study covering the years 2009-2014. A total of 182 neonates, with mean gestational age 34.1 weeks and mean body weight 2226 g, were analysed. The minimum and maximum values of the evaluated parameters were analysed statistically according to the therapy outcome noted as success or failure.
resultsA successful outcome of I-F therapy (71.4%) was characterised by higher SpO2 (93.3 ±7.28 vs. 85.9 ±14.77 at P < 0.001; 99.95 ±0.31 vs. 98.6 ±3.30 at P < 0.0001), lower heart rate (122.5 ±12.37 vs. 135.9 ±14.97 at P < 0.0001), and higher max systolic blood pressure (79.05 ±12.49 vs. 69.78 ±13.73 mm Hg at P < 0.0001), max diastolic blood pressure (57.03 ±9.31 vs. 50.41 ±13.82 mm Hg; P < 0.0003), and max as well as min mean arterial blood pressure (46.8 ±10.13 vs. 41.39 ±15.46 mm Hg; P < 0.001) (27.88 ±5.71 vs. 26.14 ±7.35 mm Hg; P < 0.02).
conclusionsIn newborns suffering from respiratory failure and treated with I-F, higher SpO2 values, lower heart rate, and higher arterial blood pressure coincide with success of the I-F therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.